Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lipid emulsion for acute aluminium phosphide poisoning
PACTR202102767216677Phase 2Recruiting
- Sponsor
- Hafsa Salah Gheat
- Start
- Jul 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of long-chain triglyceride lipid emulsion in Aluminium phosphide poisoning (2 arms), sponsored by Hafsa Salah Gheat. Primary endpoint: Mortality. Started Jul 2020; status: recruiting.
02
Drugs
long-chain triglyceride lipid emulsion
03
Conditions
Aluminium phosphide poisoning
Beyond the preview
Go deeper on PACTR202102767216677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202102767216677.